Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
7.26 USD | -1.76% | -8.99% | -35.20% |
May. 23 | Transcript : Altimmune, Inc. Presents at UBS Obesity Therapeutics Day, May-23-2024 10:00 AM | |
May. 09 | Transcript : Altimmune, Inc., Q1 2024 Earnings Call, May 09, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-35.20% | 524M | |
+12.07% | 116B | |
+12.34% | 106B | |
-9.11% | 23.89B | |
-2.24% | 21.58B | |
-10.60% | 18.96B | |
-41.25% | 16.96B | |
-14.60% | 16.33B | |
+7.57% | 14.14B | |
+31.58% | 12.02B |
- Stock Market
- Equities
- ALT Stock
- News Altimmune, Inc.
- Guggenheim Downgrades Altimmune to Neutral From Buy